NIH-funded research NIH-funded research

Metal-binding proteins and smart materials

Official title: Metalloproteins: evolution, catalysis and material design

Funded at Baylor University · NIH-11184235 · Data updated 2026-11-12

They are making metal-binding proteins and self-healing hydrogels that could help detoxify harmful chemicals and lead to new treatments for people with osteoarthritis.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBaylor University
NIH-funded
Lab location1 site (Waco, United States)
Project startSeptember 5, 2024
Project endAugust 31, 2029
Funding year2025
Award (this year)$350,000
NIH project number5R35GM155013-02
Project IDNIH-11184235 on NIH RePORTER

Who could benefit from this research

Could help

People with osteoarthritis who are interested in novel biomaterial-based therapies and willing to join future clinical studies would be the most relevant candidates.

Less likely to help

People without joint degeneration or those seeking immediate clinical relief are unlikely to benefit directly from this early-stage laboratory research.

What this research studies

The team uses NMR-guided directed evolution and other protein dynamics probes to design metal-binding proteins with much higher catalytic activity and metal affinity. They plan to create small, biocompatible protein catalysts for reactions such as DNA hydrolysis and phenol oxidation that could be used in environmental cleanup. In a separate project they are designing stimuli-responsive, antimicrobial, self-healing hydrogels aimed at treating osteoarthritis and studying how metallopeptide assemblies form. Most work is lab-based now, intended to produce materials that could move toward applied testing and future clinical trials.

Why it matters

Potential benefit: If successful, this work could yield low-cost protein catalysts for detoxification and a new hydrogel therapy that helps protect and repair osteoarthritic joints.

How similar studies have gone: Protein engineering and directed evolution have produced improved enzymes in other labs, but applying NMR-guided dynamics to predict productive mutations and combining that work with hydrogel therapeutics is relatively novel.

Where this research is happening

  • Baylor University
    Waco, United States
    Active

Researchers

  • Principal investigator: Makhlynets, Olga — Baylor University
  • Study coordinator: Makhlynets, Olga

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.